Adaptive Biotechnologies (ADPT) Enterprise Value Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) Enterprise Value Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.68% |
| Dec 31, 2025 | 0.78% |
| Sep 30, 2025 | 12.56% |
| Jun 30, 2025 | 32.19% |
| Mar 31, 2025 | 37.34% |
| Dec 31, 2024 | 35.79% |
| Sep 30, 2024 | 34.40% |
| Jun 30, 2024 | 30.01% |
| Mar 31, 2024 | 29.89% |
| Dec 31, 2023 | 30.45% |
| Sep 30, 2023 | 26.94% |
| Jun 30, 2023 | -8.75% |
| Mar 31, 2023 | -21.25% |
| Dec 31, 2022 | -41.17% |
| Sep 30, 2022 | -22.43% |
| Jun 30, 2022 | 35.86% |
| Mar 31, 2022 | 49.10% |
| Dec 31, 2021 | 48.72% |
| Sep 30, 2021 | 50.30% |
| Jun 30, 2021 | -4.89% |